Growth Hormone (GH) Therapy During the Transition Period: Should We Think About Early Retesting in Patients With Idiopathic and Isolated GH Deficiency?
International Journal of Environmental Research and Public Health - Switzerland
doi 10.3390/ijerph16030307
Full Text
Open PDFAbstract
Available in full text
Date
January 23, 2019
Authors
Publisher
MDPI AG